AI Transforms Sepsis Care With Faster, More Effective Treatments

6 months ago
23

Researchers at Day Zero Diagnostics have developed Keynome gAST, an AI-driven genomic Antimicrobial Susceptibility Test that quickly predicts antimicrobial resistance by analyzing bacterial genomes from blood samples. This breakthrough, demonstrated at ASM Microbe, could drastically improve sepsis diagnosis and treatment, speeding up decision-making and potentially saving lives amidst increasing antimicrobial resistance.

Sepsis is a life-threatening infection complication and accounts for 1.7 million hospitalizations and 350,000 deaths annually in the U.S. Fast and accurate diagnosis is critical, as mortality risk increases up to 8% every hour without effective treatment.

Loading comments...